Healthcare provider profile · identity verified

Robert Clark Frantz, D.O.

Family Practice · LILBURN, GA · NPI 1750446969

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	442	136
Atorvastatin Calcium	Atorvastatin Calcium	394	121
Rosuvastatin Calcium	Rosuvastatin Calcium	291	94
Lisinopril	Lisinopril	284	89
Levothyroxine Sodium	Levothyroxine Sodium	283	90
Zolpidem Tartrate	Zolpidem Tartrate	222	51
Metformin Hcl	Metformin Hcl	206	67
Losartan Potassium	Losartan Potassium	202	60
Pravastatin Sodium	Pravastatin Sodium	177	62
Omeprazole	Omeprazole	166	52
Alprazolam	Alprazolam	163	37
Pantoprazole Sodium	Pantoprazole Sodium	156	49
Gabapentin	Gabapentin	138	47
Furosemide	Furosemide	118	32
Meloxicam	Meloxicam	117	45
Tamsulosin Hcl	Tamsulosin Hcl	116	41
Simvastatin	Simvastatin	107	32
Hydrochlorothiazide	Hydrochlorothiazide	103	36
Ozempic	Semaglutide	102	14
Clonazepam	Clonazepam	99	18
Trazodone Hcl	Trazodone Hcl	91	34
Metformin Hcl Er	Metformin Hcl	89	31
Metoprolol Succinate	Metoprolol Succinate	87	31
Tramadol Hcl	Tramadol Hcl	80	20
Lorazepam	Lorazepam	78	14
Montelukast Sodium	Montelukast Sodium	78	27
Atenolol	Atenolol	77	23
Carvedilol	Carvedilol	77	28
Clopidogrel	Clopidogrel Bisulfate	77	24
Sertraline Hcl	Sertraline Hcl	76	27
Allopurinol	Allopurinol	75	22
Fluoxetine Hcl	Fluoxetine Hcl	74	19
Citalopram Hbr	Citalopram Hydrobromide	70	21
Potassium Chloride	Potassium Chloride	69	21
Celecoxib	Celecoxib	68	28
Escitalopram Oxalate	Escitalopram Oxalate	65	25
Glimepiride	Glimepiride	62	19
Fenofibrate	Fenofibrate	60	18
Metoprolol Tartrate	Metoprolol Tartrate	60	20
Jardiance	Empagliflozin	58	14
Mounjaro	Tirzepatide	57	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	17
Fluticasone Propionate	Fluticasone Propionate	51	17
Glipizide	Glipizide	51	14
Olmesartan Medoxomil	Olmesartan Medoxomil	51	17
Trulicity	Dulaglutide	51	suppressed
Diclofenac Sodium	Diclofenac Sodium	47	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	14
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	40	24
Famotidine	Famotidine	40	15
Glipizide Er	Glipizide	40	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	13
Nifedipine Er	Nifedipine	40	15
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	39	18
Xarelto	Rivaroxaban	36	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Valsartan	Valsartan	31	suppressed
Azelastine Hcl	Azelastine Hcl	29	13
Bupropion Xl	Bupropion Hcl	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Azithromycin	Azithromycin	28	26
Triamcinolone Acetonide	Triamcinolone Acetonide	28	18
Donepezil Hcl	Donepezil Hcl	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Eszopiclone	Eszopiclone	26	suppressed
Acyclovir	Acyclovir	25	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Eliquis	Apixaban	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Prednisone	Prednisone	23	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	20	suppressed
Diazepam	Diazepam	20	11
Methylprednisolone	Methylprednisolone	20	16
Zolpidem Tartrate Er	Zolpidem Tartrate	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Linzess	Linaclotide	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Finasteride	Finasteride	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Fluconazole	Fluconazole	17	12
Klor-Con M20	Potassium Chloride	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Testosterone	Testosterone	17	suppressed
Baclofen	Baclofen	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Terazosin Hcl	Terazosin Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Telmisartan	Telmisartan	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Pentoxifylline	Pentoxifylline	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error